Close Menu

Frank D'Amelio and Ian Read, respectively the CFO and the head of biopharmaceuticals at Pfizer, will each receive about a million dollar bonus, according to the Wall Street Journal Health Blog. They showed, according to the board's compensation committee, "devoted extraordinary efforts and made extraordinary contributions" to the Pfizer-Wyeth merger. The Health Blog notes that Pfizer plans to eliminate 20,000 jobs due to the merger.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.